PT1034185E - Composicoes farmaceuticas que contem a pentraxina longa ptx3 - Google Patents
Composicoes farmaceuticas que contem a pentraxina longa ptx3Info
- Publication number
- PT1034185E PT1034185E PT98962665T PT98962665T PT1034185E PT 1034185 E PT1034185 E PT 1034185E PT 98962665 T PT98962665 T PT 98962665T PT 98962665 T PT98962665 T PT 98962665T PT 1034185 E PT1034185 E PT 1034185E
- Authority
- PT
- Portugal
- Prior art keywords
- ptx3
- pharmaceutical compositions
- compositions containing
- long pentraxin
- containing long
- Prior art date
Links
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 title abstract 4
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 title abstract 4
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 101100352284 Homo sapiens PITX3 gene Proteins 0.000 abstract 1
- 101100031710 Homo sapiens PTX3 gene Proteins 0.000 abstract 1
- 108700025763 PTX3 Proteins 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- -1 human PTX3 Natural products 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000796A IT1298487B1 (it) | 1997-12-19 | 1997-12-19 | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1034185E true PT1034185E (pt) | 2005-07-29 |
Family
ID=11405409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98962665T PT1034185E (pt) | 1997-12-19 | 1998-12-16 | Composicoes farmaceuticas que contem a pentraxina longa ptx3 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8003109B2 (https=) |
| EP (1) | EP1034185B1 (https=) |
| JP (1) | JP4173633B2 (https=) |
| KR (1) | KR100560085B1 (https=) |
| AT (1) | ATE295853T1 (https=) |
| AU (1) | AU756974B2 (https=) |
| CA (1) | CA2315277C (https=) |
| DE (1) | DE69830251T2 (https=) |
| ES (1) | ES2242309T3 (https=) |
| IT (1) | IT1298487B1 (https=) |
| NZ (1) | NZ505063A (https=) |
| PT (1) | PT1034185E (https=) |
| WO (1) | WO1999032516A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298487B1 (it) | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| IT1317927B1 (it) * | 2000-11-03 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
| IT1317930B1 (it) * | 2000-11-08 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione |
| US20040198655A1 (en) * | 2001-08-03 | 2004-10-07 | Alberto Mantovani | Use of long pentraxin ptx3 for treating female infertility |
| US7041648B2 (en) | 2001-08-03 | 2006-05-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Compositions and methods for treating female fertility |
| ITRM20020109A1 (it) * | 2002-02-28 | 2003-08-28 | Sigma Tau Ind Farmaceuti | Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. |
| ITRM20020191A1 (it) * | 2002-04-08 | 2003-10-08 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att |
| ITRM20030596A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
| ITRM20040223A1 (it) * | 2004-05-07 | 2004-08-07 | Sigma Tau Ind Farmaceuti | Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. |
| ITRM20040489A1 (it) * | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
| JP5427415B2 (ja) * | 2006-01-24 | 2014-02-26 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | Ｆｇｆ２結合性ペプチドおよびそれらの使用 |
| EP1832295A1 (en) | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
| PT2012816E (pt) * | 2006-05-02 | 2012-08-17 | Sigma Tau Ind Farmaceuti | Uso de timosina 1, isolada ou em combinação com ptx3 ou ganciclovir, para o tratamento da infeção por citomegalovírus |
| WO2009095403A1 (en) * | 2008-01-29 | 2009-08-06 | Tecnogen S.P.A. | Expression system and uses thereof for the production of human long pentraxin 3 |
| HRP20130947T1 (hr) | 2009-07-29 | 2013-11-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Poboljšani sustav za eksprimiranje ljudskog dugog pentraksina 3 i njegova upotreba |
| KR101305515B1 (ko) | 2011-06-10 | 2013-09-06 | 경북대학교 산학협력단 | 펜트락신 3 단백질의 파킨슨 질환 진단 용도 |
| WO2013191280A1 (ja) * | 2012-06-22 | 2013-12-27 | 国立大学法人 東京大学 | 全身性炎症反応症候群の治療又は予防剤 |
| TWI528969B (zh) * | 2013-06-07 | 2016-04-11 | 國立成功大學 | 胺基酸序列用於製備抑制ｐｔｘ３治療鼻咽癌之醫藥組合物之用途 |
| TWI531375B (zh) | 2015-05-29 | 2016-05-01 | 國立成功大學 | 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物 |
| CN105132459B (zh) * | 2015-09-14 | 2019-01-29 | 武汉市星熠艾克生物医药有限责任公司 | 人类ptx3重组蛋白的制备方法及应用 |
| EP4103592A4 (en) * | 2020-02-12 | 2024-01-10 | BioTissue Holdings Inc. | METHODS OF DESTRUCTING OR INHIBITING THE GROWTH OF CANCER CELLS |
| US20230227511A1 (en) * | 2020-05-14 | 2023-07-20 | Nippon Medical School Foundation | Therapeutic or preventive agent for infectious disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196564B (it) * | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
| JPH06506195A (ja) * | 1991-01-14 | 1994-07-14 | ニューヨーク ユニバシテイ | サイトカイン誘導タンパク質、ｔｓｇ−１４、そのためのｄｎａコード化およびその使用 |
| IT1254687B (it) * | 1992-04-14 | 1995-09-28 | Italfarmaco Spa | Gene inducibile da citochine |
| US6210941B1 (en) * | 1997-06-27 | 2001-04-03 | The Trustees Of Boston University | Methods for the detection and isolation of proteins |
| US5632983A (en) * | 1994-11-17 | 1997-05-27 | University Of South Florida | Method for treating secondary immunodeficiency |
| US5939423A (en) * | 1997-04-16 | 1999-08-17 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
| IT1298487B1 (it) | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| IT1317927B1 (it) * | 2000-11-03 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
| IT1317930B1 (it) * | 2000-11-08 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione |
| US6872541B2 (en) * | 2001-07-25 | 2005-03-29 | Coulter International Corp. | Method and compositions for analysis of pentraxin receptors as indicators of disease |
| US7041648B2 (en) * | 2001-08-03 | 2006-05-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Compositions and methods for treating female fertility |
| US20040198655A1 (en) * | 2001-08-03 | 2004-10-07 | Alberto Mantovani | Use of long pentraxin ptx3 for treating female infertility |
| US20040137544A1 (en) * | 2002-10-31 | 2004-07-15 | Roberto Latini | PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies |
| WO2004094991A2 (en) | 2003-04-23 | 2004-11-04 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| ITRM20030596A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
| ITRM20040489A1 (it) * | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
| EP1832295A1 (en) * | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
| PT2012816E (pt) * | 2006-05-02 | 2012-08-17 | Sigma Tau Ind Farmaceuti | Uso de timosina 1, isolada ou em combinação com ptx3 ou ganciclovir, para o tratamento da infeção por citomegalovírus |
-
1997
- 1997-12-19 IT IT97RM000796A patent/IT1298487B1/it active IP Right Grant
-
1998
- 1998-12-16 PT PT98962665T patent/PT1034185E/pt unknown
- 1998-12-16 NZ NZ505063A patent/NZ505063A/xx not_active IP Right Cessation
- 1998-12-16 DE DE69830251T patent/DE69830251T2/de not_active Expired - Lifetime
- 1998-12-16 JP JP2000525453A patent/JP4173633B2/ja not_active Expired - Fee Related
- 1998-12-16 AT AT98962665T patent/ATE295853T1/de active
- 1998-12-16 ES ES98962665T patent/ES2242309T3/es not_active Expired - Lifetime
- 1998-12-16 KR KR1020007006739A patent/KR100560085B1/ko not_active Expired - Fee Related
- 1998-12-16 AU AU17829/99A patent/AU756974B2/en not_active Ceased
- 1998-12-16 EP EP98962665A patent/EP1034185B1/en not_active Expired - Lifetime
- 1998-12-16 WO PCT/IT1998/000364 patent/WO1999032516A2/en not_active Ceased
- 1998-12-16 CA CA2315277A patent/CA2315277C/en not_active Expired - Fee Related
-
2007
- 2007-07-31 US US11/882,180 patent/US8003109B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE295853T1 (de) | 2005-06-15 |
| JP4173633B2 (ja) | 2008-10-29 |
| JP2002503642A (ja) | 2002-02-05 |
| EP1034185B1 (en) | 2005-05-18 |
| US20080015153A1 (en) | 2008-01-17 |
| WO1999032516A2 (en) | 1999-07-01 |
| KR20010033297A (ko) | 2001-04-25 |
| US8003109B2 (en) | 2011-08-23 |
| WO1999032516A3 (en) | 1999-10-28 |
| CA2315277C (en) | 2010-02-23 |
| AU1782999A (en) | 1999-07-12 |
| DE69830251D1 (de) | 2005-06-23 |
| KR100560085B1 (ko) | 2006-03-13 |
| ITRM970796A1 (it) | 1999-06-19 |
| IT1298487B1 (it) | 2000-01-10 |
| CA2315277A1 (en) | 1999-07-01 |
| NZ505063A (en) | 2002-12-20 |
| AU756974B2 (en) | 2003-01-30 |
| ES2242309T3 (es) | 2005-11-01 |
| EP1034185A2 (en) | 2000-09-13 |
| DE69830251T2 (de) | 2005-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1034185E (pt) | Composicoes farmaceuticas que contem a pentraxina longa ptx3 | |
| UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
| BR9914643A (pt) | Vetores adeno-associados para expressão dofator viii por células alvo | |
| EP1637608A3 (en) | Recombinant adenoviral vector and methods of use | |
| ATE286118T1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
| TW428026B (en) | Bifunctional protein, preparation and use | |
| ATE298253T1 (de) | In vivo gentransfermethoden zur wundheilung | |
| NO962791D0 (no) | Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse | |
| ES2155702T4 (es) | Construcciones expresivas halteroformes para la terapia genetica. | |
| ZA942778B (en) | Recombinant viruses, and their preparation and use in gene therapy. | |
| ZA956678B (en) | Adenovirus comprising a gene encoding glutathione peroxidase | |
| FI973309A0 (fi) | Menetelmä yhdistelmä-DNA-adenovirusgenomin valmistamiseksi | |
| ES2153358T3 (es) | Procedimientos para la seleccion de celulas huespedes recombinantes que expresan altos niveles de una proteina deseada. | |
| BR9609853A (pt) | Estruturas com manifestação de p16 e sua aplicação na terapia de cncer. | |
| BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
| AU2164197A (en) | Recombinant adenoviral vectors for human tumour gene therapy | |
| WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
| DK1144600T3 (da) | Akt-3-nukleinsyre, polypeptider og anvendelser deraf | |
| PT1007717E (pt) | Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta | |
| ATE174629T1 (de) | Herstellung von proteinen mittels protein 7b2 | |
| NO915084L (no) | Fremgangsmaate ved fremstilling av human interleukin-5 receptor | |
| DK0781344T3 (da) | Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme | |
| BR9708005A (pt) | C3 convertase resistente à regulação para baixo | |
| ATE355385T1 (de) | Herstellung von rekombinanten adenoviren und von adenovirus-genbanken | |
| NO941982L (no) | Fremstilling av proteiner ved anvendelse av 7B2 protein |